Preventing recurrence of focal segmental glomerulosclerosis following renal transplantation: A case report

Abstract:  While the recurrence of FSGS in a primary renal transplant has been well studied, strategies to prevent subsequent recurrence in later transplants, has not been well formulated. This is important considering that one center's experience with adults reported an initial recurrence rate of 57% with reoccurrence of 37% in subsequent transplants. However, renal function was maintained in 62% ( 1 ). In pediatrics, data from a single‐center reported 100% recurrence of FSGS in the second allograft after an initial recurrence of 52% ( 2 ). Two commentaries reviewing such data, one each in adults and pediatrics, suggested that the benefits of living‐related donation might not be realized in patients with FSGS because of this frequent recurrence ( 3, 4 ). Here, we report a patient who was considered to be at very high risk for post‐transplant recurrence of FSGS, because of the established risk factors, who was successfully retransplanted after a course of pretransplant plasmapheresis, followed by post‐transplant plasmapheresis and the use of cyclosporine. Eighteen months post‐transplant, he has no proteinuria and his serum creatinine is 1.2 mg/dL.

[1]  G. Mayer,et al.  [Primary glomerulonephritis]. , 2006, Wiener klinische Wochenschrift.

[2]  M. Boeckh,et al.  Emerging viral infections after hematopoietic cell transplantation , 2005, Pediatric transplantation.

[3]  G. Ghiggeri,et al.  New Insights into the Pathogenesis and the Therapy of Recurrent Focal Glomerulosclerosis , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[4]  G. Ciancio,et al.  Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience , 2005, Pediatric Nephrology.

[5]  B. Jaar,et al.  High-Dose Mycophenolate Mofetil in the Treatment of Posttransplant Glomerular Disease in the Allograft: A Case Series , 2004, Nephron Clinical Practice.

[6]  M. Baum.  Outcomes after renal transplantation for FSGS in children , 2004, Pediatric transplantation.

[7]  O. Gribouval,et al.  NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. , 2004, Kidney international.

[8]  L. Travis,et al.  High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  A. Kassir,et al.  Recurrent nephrotic syndrome after transplantation: Early treatment with plasmaphaeresis and cyclophosphamide , 1993, Pediatric Nephrology.

[10]  M. First.  Living-related donor transplants should be performed with caution in patients with focal segmental glomerulosclerosis , 2004, Pediatric Nephrology.

[11]  R. Salomon,et al.  Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children , 2003, Transplantation.

[12]  D. Stablein,et al.  Outcome of renal transplantation in adolescents with focal segmental glomerulosclerosis , 2002, Pediatric transplantation.

[13]  M. Fujisawa,et al.  Long-term outcome of focal segmental glomerulosclerosis after Japanese pediatric renal transplantation , 2002, Pediatric Nephrology.

[14]  M. Nagata,et al.  EFFECT OF PRE- AND POSTOPERATIVE PLASMAPHERESIS ON POSTTRANSPLANT RECURRENCE OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN CHILDREN , 2001, Transplantation.

[15]  D. Stablein,et al.  Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. , 2001, Kidney international.

[16]  G. Ghiggeri,et al.  Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  J. Wetzels,et al.  Recurrent focal glomerulosclerosis: natural course and treatment with plasma exchange. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  B. Hall,et al.  Mycophenolate mofetil prevents the induction of active Heymann nephritis: association with Th2 cytokine inhibition. , 1998, Journal of the American Society of Nephrology : JASN.

[19]  B. Walgreen,et al.  Attenuation of murine lupus nephritis by mycophenolate mofetil. , 1998, Journal of the American Society of Nephrology : JASN.

[20]  S. Swan,et al.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. , 1996, The New England journal of medicine.

[21]  S. Knechtle,et al.  The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. , 1996, Transplantation.

[22]  V. Savin,et al.  Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  B. Chavers,et al.  Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis. , 1992, Transplantation.

[24]  J. Soulillou,et al.  RECURRENT NEPHROTIC SYNDROME FOLLOWING RENAL TRANSPLANTATION IN PATIENTS WITH FOCAL GLOMERULOSCLEROSIS: A ONE‐CENTER STUDY OF PLASMA EXCHANGE EFFECTS , 1991, Transplantation.

[25]  E. Ingulli,et al.  Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience. , 1991, Transplantation.

[26]  N. Modiano.  The Children. , 1898 .